John Leonard Maiocco, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd, Suite 420, Trumbull, CT 06611 Phone: 203-374-3464 Fax: 203-372-1975 |
Dr. Robert Anthony Eterno, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 112 Quarry Rd, Suite 420, Trumbull, CT 06611 Phone: 203-374-1700 Fax: 203-372-1975 |
Primed, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4154 Madison Ave, Trumbull, CT 06611 Phone: 203-374-1700 Fax: 203-372-1975 |
Foot Specialists Of Trumbull Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4154 Madison Ave, Trumbull, CT 06611 Phone: 203-374-1700 Fax: 203-372-1975 |
News Archive
Researchers at the University of Kentucky's Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study.
A new test has the potential to help physicians identify patients with the most lethal forms of triple-negative breast cancer, a disease which requires aggressive and innovative treatment.
Adding quinoa to the gluten-free diet of patients with celiac disease is well-tolerated, and does not exacerbate the condition, according to new research published in The American Journal of Gastroenterology. Dr. Victor F. Zevallos, from the Department of Gastroenterology, King's College London, United Kingdom, evaluated the in-vivo effects of consuming quinoa in adult celiac patients. Quinoa, a highly nutritious grain, is traditionally recommended as part of a gluten-free diet.
Maybe you've heard that milk is the perfect way to extinguish that spicy food burn. Why is milk so effective? And what if you can't drink milk?
BioMimetic Therapeutics, Inc., announced today the closing of its previously announced underwritten public offering. Prior to closing, the underwriters exercised their option to purchase an additional approximately 642,000 shares of common stock. As a result, BioMimetic sold a total of approximately 5.64 million shares of its common stock at a price to the public of $8.50 per share.
› Verified 1 days ago